{"transactions":[{"id":909607,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T02:00:15.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":17730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":17730,"derivative":{"exercise_price":16.37,"expiration_date":"2036-02-09","underlying":"Common Stock","underlying_shares":17730},"source":{"system":"sec-edgar","filing":"0001140361-26-004889","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126004889/form4.xml","form_type":"4"}},{"id":909606,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-02-12T02:00:15.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":10690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; (ii) 5,445 RSUs out of 10,889 RSUs granted on February 19, 2025, which will vest fully on February 19, 2026, subject to the Reporting Person's continued service as of such vesting date; and (iii) 246,885 shares of common stock owned by the Reporting Person."}],"balance_after":263020,"source":{"system":"sec-edgar","filing":"0001140361-26-004889","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126004889/form4.xml","form_type":"4"}},{"id":1252447,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-02-22T02:05:33.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":16279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":16279,"derivative":{"exercise_price":16.07,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":16279},"source":{"system":"sec-edgar","filing":"0001140361-25-005540","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125005540/form4.xml","form_type":"4"}},{"id":1252446,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-22T02:05:33.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":false,"shares":10889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 10,889 RSUs granted on February 19, 2025 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 12,020 RSUs granted on February 26, 2024, which will vest in full on February 26, 2024, subject to the Reporting Person's continued service as of such vesting date; and (iii) 229,421 shares of common stock owned by the reporting person."}],"balance_after":252330,"source":{"system":"sec-edgar","filing":"0001140361-25-005540","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125005540/form4.xml","form_type":"4"}},{"id":1421716,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-28T01:00:24.000Z","date":"2024-08-23","kind":"sale","planned":false,"acquired":false,"shares":60000,"price":18.26,"value":1095600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $18.25 to $18.27.  The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 12,020 restricted stock units (\"RSUs\") granted on February 26, 2024, which will vest in full on February 26, 2025, subject to the Reporting Person's continued service as of the applicable vesting date; and (ii) 229,421 shares of common stock owned by the Reporting Person."}],"balance_after":241441,"source":{"system":"sec-edgar","filing":"0001140361-24-038770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124038770/form4.xml","form_type":"4"}},{"id":1611847,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-02-29T02:00:45.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":37541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":37541,"derivative":{"exercise_price":5.4,"expiration_date":"2034-02-26","underlying":"Common Stock","underlying_shares":37541},"source":{"system":"sec-edgar","filing":"0001140361-24-010239","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124010239/form4.xml","form_type":"4"}},{"id":1611846,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-29T02:00:45.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":24040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 24,040 RSUs granted on February 26, 2024 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 25,815 RSUs granted on March 6, 2023, which will vest in full on March 6, 2024; and (iii) 251,586 shares of common stock owned by the reporting person."}],"balance_after":301441,"source":{"system":"sec-edgar","filing":"0001140361-24-010239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124010239/form4.xml","form_type":"4"}},{"id":1797486,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-24T23:53:31.000Z","date":"2023-08-24","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":3.9,"value":97500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023, that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date and (ii) 251,586 shares of common stock owned by the reporting person."}],"balance_after":277401,"source":{"system":"sec-edgar","filing":"0001140361-23-041191","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123041191/form4.xml","form_type":"4"}},{"id":1962759,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":true}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-09T02:30:33.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":51630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":51630,"derivative":{"exercise_price":3.35,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":51630},"source":{"system":"sec-edgar","filing":"0001140361-23-010768","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123010768/form4.xml","form_type":"4"}},{"id":1962758,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-09T02:30:33.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":25815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 13,293 RSUs granted on March 7, 2022, which will vest in full on March 7, 2023; and (iii) 213,293 shares of common stock owned by the reporting person."}],"balance_after":252401,"source":{"system":"sec-edgar","filing":"0001140361-23-010768","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123010768/form4.xml","form_type":"4"}},{"id":2341317,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":true}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-09T22:59:18.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":53172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":53172,"derivative":{"exercise_price":1.67,"expiration_date":"2032-03-07","underlying":"Common Stock","underlying_shares":53172},"source":{"system":"sec-edgar","filing":"0001140361-22-008677","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036122008677/form4.xml","form_type":"4"}},{"id":2341316,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-09T22:59:18.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":26586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 26,586 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); and (ii) 200,000 shares of common stock owned by the reporting person."}],"balance_after":226586,"source":{"system":"sec-edgar","filing":"0001140361-22-008677","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036122008677/form4.xml","form_type":"4"}},{"id":2534410,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-26T11:00:49.000Z","date":"2021-10-25","kind":"purchase","acquired":true,"shares":100000,"price":1,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the October 2021 public offering of the issuer."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001140361-21-035382","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036121035382/form4.xml","form_type":"4"}},{"id":2540378,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-10-18T22:21:17.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":93500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of a stock option to purchase 93,500 shares of common stock, $0.0001 par value per share (\"Common Stock\") of ADMA Biologics, Inc. The shares of Common Stock underlying the stock option will vest in 12 equal monthly installments, becoming fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service on the applicable vesting date."}],"balance_after":93500,"derivative":{"exercise_price":1.1,"expiration_date":"2031-10-15","underlying":"Common Stock","underlying_shares":93500},"source":{"system":"sec-edgar","filing":"0001140361-21-034767","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036121034767/form4.xml","form_type":"4"}},{"id":3018350,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":96863,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":31.87,"expiration_date":"2030-02-07","underlying":"Common Stock","underlying_shares":96863},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018349,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":115656,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":12.76,"expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":115656},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018348,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":38334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":18.85,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":38334},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018347,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":35437,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":10.83,"expiration_date":"2026-02-09","underlying":"Common Stock","underlying_shares":35437},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018346,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":6786,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":21.56,"expiration_date":"2025-08-11","underlying":"Common Stock","underlying_shares":6786},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018345,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":13013,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":13.02,"expiration_date":"2025-02-18","underlying":"Common Stock","underlying_shares":13013},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018344,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":1356,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":17.96,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1356},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018343,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":7228,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":12.58,"expiration_date":"2023-02-19","underlying":"Common Stock","underlying_shares":7228},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018342,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":8502,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":13.26,"expiration_date":"2021-02-22","underlying":"Common Stock","underlying_shares":8502},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018341,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":3137,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":31.87,"expiration_date":"2030-02-07","underlying":"Common Stock","underlying_shares":3137},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018340,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":19344,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":12.76,"expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":19344},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018339,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":6766,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":18.85,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":6766},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018338,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":2363,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":10.83,"expiration_date":"2026-02-09","underlying":"Common Stock","underlying_shares":2363},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018337,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":3214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":21.56,"expiration_date":"2025-08-11","underlying":"Common Stock","underlying_shares":3214},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018336,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":6712,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":13.02,"expiration_date":"2025-02-18","underlying":"Common Stock","underlying_shares":6712},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018335,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":3466,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":17.96,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":3466},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018334,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":3572,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":12.58,"expiration_date":"2023-02-19","underlying":"Common Stock","underlying_shares":3572},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018333,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Restricted Stock Units","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018332,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":31500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018331,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Restricted Stock Units","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":2819,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2819},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018330,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Reflects disposition of Issuer restricted stock units in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) the Offer Price."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3018329,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-10-01T17:05:24.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":160633,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by that certain Agreement and Plan of Merger, dated as of August 19, 2020 (the \"Merger Agreement\"), by and among Johnson & Johnson, Vigor Sub, Inc. (\"Merger Sub\") and the Issuer, including the completion of a tender offer to purchase all of the outstanding shares of Issuer common stock at a price of $52.50 per share in cash, without interest, less any required withholding taxes (the \"Offer Price\"), and the consummation of the merger (the \"Merger\") between the Issuer and Merger Sub on October 1, 2020.  Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled in exchange for the right to receive an amount equal to the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-20-010056","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010056/edgar.xml","form_type":"4"}},{"id":3061688,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Restricted Stock Units","published_at":"2020-08-11T16:41:41.000Z","date":"2020-08-07","kind":"exercise","acquired":false,"shares":1410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":2819,"derivative":{"underlying":"Common Stock","underlying_shares":1410},"source":{"system":"sec-edgar","filing":"0001179110-20-008885","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008885/edgar.xml","form_type":"4"}},{"id":3061687,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-08-11T16:41:41.000Z","date":"2020-08-10","kind":"sale","acquired":false,"shares":652,"price":32.36,"value":21098.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":160633,"source":{"system":"sec-edgar","filing":"0001179110-20-008885","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008885/edgar.xml","form_type":"4"}},{"id":3061686,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-08-11T16:41:41.000Z","date":"2020-08-07","kind":"exercise","acquired":true,"shares":1410,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":161285,"source":{"system":"sec-edgar","filing":"0001179110-20-008885","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008885/edgar.xml","form_type":"4"}},{"id":3078651,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Restricted Stock Units","published_at":"2020-07-21T16:02:55.000Z","date":"2020-07-17","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17,2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":31500,"derivative":{"underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001179110-20-008395","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008395/edgar.xml","form_type":"4"}},{"id":3078650,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-07-21T16:02:55.000Z","date":"2020-07-20","kind":"sale","acquired":false,"shares":1561,"price":33.95,"value":52995.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":159875,"source":{"system":"sec-edgar","filing":"0001179110-20-008395","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008395/edgar.xml","form_type":"4"}},{"id":3078649,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-07-21T16:02:55.000Z","date":"2020-07-17","kind":"exercise","acquired":true,"shares":3500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17,2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":161436,"source":{"system":"sec-edgar","filing":"0001179110-20-008395","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008395/edgar.xml","form_type":"4"}},{"id":3095029,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Restricted Stock Units","published_at":"2020-07-01T21:15:05.000Z","date":"2020-06-29","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of MNTA Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, 15,000 Restricted Stock Units will vest on June 29, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, 15,000 Restricted Stock Units will vest on June 29, 2021."}],"balance_after":45000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-20-080018","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000110465920080018/a4.xml","form_type":"4"}},{"id":3095028,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-07-01T21:15:05.000Z","date":"2020-06-30","kind":"sale","acquired":false,"shares":6810,"price":35.11,"value":239099.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan"}],"balance_after":157936,"source":{"system":"sec-edgar","filing":"0001104659-20-080018","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000110465920080018/a4.xml","form_type":"4"}},{"id":3095027,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-07-01T21:15:05.000Z","date":"2020-06-29","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Performance Stock Units that were granted on October 17, 2018."}],"balance_after":164746,"source":{"system":"sec-edgar","filing":"0001104659-20-080018","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000110465920080018/a4.xml","form_type":"4"}},{"id":3110304,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Restricted Stock Units","published_at":"2020-06-15T17:21:12.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of MNTA Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, 15,000 Restricted Stock Units will vest on June 11, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, 15,000 Restricted Stock Units will vest on June 11, 2021."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001179110-20-007356","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020007356/edgar.xml","form_type":"4"}},{"id":3110303,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-06-15T17:21:12.000Z","date":"2020-06-12","kind":"sale","acquired":false,"shares":6756,"price":30.15,"value":203693.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan"}],"balance_after":149746,"source":{"system":"sec-edgar","filing":"0001179110-20-007356","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020007356/edgar.xml","form_type":"4"}},{"id":3110302,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-06-15T17:21:12.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Performance Stock Units that were granted on October 17, 2018."}],"balance_after":156502,"source":{"system":"sec-edgar","filing":"0001179110-20-007356","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020007356/edgar.xml","form_type":"4"}},{"id":3154188,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Restricted Stock Units","published_at":"2020-05-11T16:20:54.000Z","date":"2020-05-07","kind":"exercise","acquired":false,"shares":1409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":4229,"derivative":{"underlying":"Common Stock","underlying_shares":1409},"source":{"system":"sec-edgar","filing":"0001179110-20-005717","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020005717/edgar.xml","form_type":"4"}},{"id":3154187,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-05-11T16:20:54.000Z","date":"2020-05-08","kind":"sale","acquired":false,"shares":629,"price":33.3,"value":20945.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":141502,"source":{"system":"sec-edgar","filing":"0001179110-20-005717","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020005717/edgar.xml","form_type":"4"}},{"id":3154186,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-05-11T16:20:54.000Z","date":"2020-05-07","kind":"exercise","acquired":true,"shares":1409,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":142131,"source":{"system":"sec-edgar","filing":"0001179110-20-005717","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020005717/edgar.xml","form_type":"4"}},{"id":3172295,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Restricted Stock Units","published_at":"2020-04-21T16:20:10.000Z","date":"2020-04-17","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17,2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":35000,"derivative":{"underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001179110-20-004999","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020004999/edgar.xml","form_type":"4"}},{"id":3172294,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-04-21T16:20:10.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":1614,"price":28.97,"value":46757.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":140722,"source":{"system":"sec-edgar","filing":"0001179110-20-004999","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020004999/edgar.xml","form_type":"4"}},{"id":3172293,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-04-21T16:20:10.000Z","date":"2020-04-17","kind":"exercise","acquired":true,"shares":3500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17,2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":142336,"source":{"system":"sec-edgar","filing":"0001179110-20-004999","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020004999/edgar.xml","form_type":"4"}},{"id":3220213,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-09T17:17:18.000Z","date":"2020-03-05","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one share of MNTA Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to the officer's continued employment with the company, the Restricted Stock Units will vest on March 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to the officer's continued employment with the company, the Restricted Stock Units will vest on March 5, 2021."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001179110-20-003316","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020003316/edgar.xml","form_type":"4"}},{"id":3220212,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-03-09T17:17:18.000Z","date":"2020-03-06","kind":"sale","acquired":false,"shares":7356,"price":28.96,"value":213029.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan"}],"balance_after":138836,"source":{"system":"sec-edgar","filing":"0001179110-20-003316","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020003316/edgar.xml","form_type":"4"}},{"id":3220211,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-03-09T17:17:18.000Z","date":"2020-03-05","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Performance Stock Units that were granted on October 17, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,089 shares acquired under the issuer's employee stock purchase plan at a price of $9.76 per share on January 31, 2020."}],"balance_after":146192,"source":{"system":"sec-edgar","filing":"0001179110-20-003316","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020003316/edgar.xml","form_type":"4"}},{"id":3270317,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-14T18:54:46.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 12, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001179110-20-001670","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020001670/edgar.xml","form_type":"4"}},{"id":3270316,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-02-14T18:54:46.000Z","date":"2020-02-13","kind":"sale","acquired":false,"shares":9016,"price":30.03,"value":270750.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":130103,"source":{"system":"sec-edgar","filing":"0001179110-20-001670","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020001670/edgar.xml","form_type":"4"}},{"id":3270315,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-02-14T18:54:46.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":27500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":139119,"source":{"system":"sec-edgar","filing":"0001179110-20-001670","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020001670/edgar.xml","form_type":"4"}},{"id":3276558,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-02-12T17:27:37.000Z","date":"2020-02-11","kind":"sale","acquired":false,"shares":350,"price":32.23,"value":11280.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":111619,"source":{"system":"sec-edgar","filing":"0001179110-20-001522","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020001522/edgar.xml","form_type":"4"}},{"id":3279490,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-11T19:02:16.000Z","date":"2020-02-07","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Subject to certain criteria, the stock option will vest and become exercisable with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":100000,"derivative":{"exercise_price":31.87,"expiration_date":"2030-02-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001179110-20-001468","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020001468/edgar.xml","form_type":"4"}},{"id":3279489,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-11T19:02:16.000Z","date":"2020-02-07","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each Restricted Stock Unit represents a contingent right to receive one share of MMTA common stock."},{"field":"shares","element":"transactionShares","label":"F7","text":"Represents restricted stock units granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-20-001468","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020001468/edgar.xml","form_type":"4"}},{"id":3279488,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-11T19:02:16.000Z","date":"2020-02-07","kind":"exercise","acquired":false,"shares":1409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":5638,"derivative":{"underlying":"Common Stock","underlying_shares":1409},"source":{"system":"sec-edgar","filing":"0001179110-20-001468","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020001468/edgar.xml","form_type":"4"}},{"id":3279487,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-02-11T19:02:16.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":408,"price":31.5,"value":12852.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":111969,"source":{"system":"sec-edgar","filing":"0001179110-20-001468","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020001468/edgar.xml","form_type":"4"}},{"id":3279486,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-02-11T19:02:16.000Z","date":"2020-02-07","kind":"exercise","acquired":true,"shares":1409,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":112377,"source":{"system":"sec-edgar","filing":"0001179110-20-001468","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020001468/edgar.xml","form_type":"4"}},{"id":3305134,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Restricted Stock Units","published_at":"2020-01-22T17:13:53.000Z","date":"2020-01-17","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17,2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":38500,"derivative":{"underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001179110-20-000699","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020000699/edgar.xml","form_type":"4"}},{"id":3305133,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-01-22T17:13:53.000Z","date":"2020-01-21","kind":"sale","acquired":false,"shares":1235,"price":30.08,"value":37148.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":110968,"source":{"system":"sec-edgar","filing":"0001179110-20-000699","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020000699/edgar.xml","form_type":"4"}},{"id":3305132,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial & Bus. Officer"}}],"security":"Common Stock","published_at":"2020-01-22T17:13:53.000Z","date":"2020-01-17","kind":"exercise","acquired":true,"shares":3500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17,2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":112203,"source":{"system":"sec-edgar","filing":"0001179110-20-000699","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020000699/edgar.xml","form_type":"4"}},{"id":3372702,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-11-13T17:12:01.000Z","date":"2019-11-12","kind":"sale","acquired":false,"shares":529,"price":16.18,"value":8559.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":108703,"source":{"system":"sec-edgar","filing":"0001179110-19-011659","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019011659/edgar.xml","form_type":"4"}},{"id":3374218,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2019-11-12T16:21:57.000Z","date":"2019-11-07","kind":"exercise","acquired":false,"shares":1410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":7047,"derivative":{"underlying":"Common Stock","underlying_shares":1410},"source":{"system":"sec-edgar","filing":"0001179110-19-011615","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019011615/edgar.xml","form_type":"4"}},{"id":3374217,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-11-12T16:21:57.000Z","date":"2019-11-08","kind":"sale","acquired":false,"shares":632,"price":16.06,"value":10149.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":109232,"source":{"system":"sec-edgar","filing":"0001179110-19-011615","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019011615/edgar.xml","form_type":"4"}},{"id":3374216,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-11-12T16:21:57.000Z","date":"2019-11-07","kind":"exercise","acquired":true,"shares":1410,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":109864,"source":{"system":"sec-edgar","filing":"0001179110-19-011615","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019011615/edgar.xml","form_type":"4"}},{"id":3390101,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2019-10-21T16:20:58.000Z","date":"2019-10-17","kind":"exercise","acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17,2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":42000,"derivative":{"underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001179110-19-011134","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019011134/edgar.xml","form_type":"4"}},{"id":3390100,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-10-21T16:20:58.000Z","date":"2019-10-18","kind":"sale","acquired":false,"shares":6365,"price":13.83,"value":88027.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":108454,"source":{"system":"sec-edgar","filing":"0001179110-19-011134","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019011134/edgar.xml","form_type":"4"}},{"id":3390099,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-10-21T16:20:58.000Z","date":"2019-10-17","kind":"exercise","acquired":true,"shares":14000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on October 17,2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":114819,"source":{"system":"sec-edgar","filing":"0001179110-19-011134","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019011134/edgar.xml","form_type":"4"}},{"id":3439834,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-08-13T17:03:35.000Z","date":"2019-08-12","kind":"sale","acquired":false,"shares":533,"price":11.64,"value":6204.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":100819,"source":{"system":"sec-edgar","filing":"0001179110-19-009459","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019009459/edgar.xml","form_type":"4"}},{"id":3439801,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-08-13T16:47:52.000Z","date":"2019-08-08","kind":"sale","acquired":false,"shares":636,"price":11.67,"value":7422.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The original Form 4 filed on August 9, 2019 is amended by this Form 4/A to correctly reflect the reporting person's share disposal of 636, not 626 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The original Form 4 filed on August 9, 2019 is amended by this Form 4/A to correctly reflect the reporting person's selling price of $11.67 per share, not $11.82 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The original Form 4 filed on August 9, 2019 is amended by this Form 4/A to correctly reflect the reporting person's ownership balance of 101,352, not 101,362 shares of common stock."}],"balance_after":101352,"source":{"system":"sec-edgar","filing":"0001179110-19-009447","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019009447/edgar.xml","form_type":"4/A","original_submission_date":"2019-08-09"}},{"id":3442218,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2019-08-09T16:20:01.000Z","date":"2019-08-07","kind":"exercise","acquired":true,"shares":1409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":8457,"derivative":{"underlying":"Common Stock","underlying_shares":1409},"source":{"system":"sec-edgar","filing":"0001179110-19-009338","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019009338/edgar.xml","form_type":"4"}},{"id":3442217,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-08-09T16:20:01.000Z","date":"2019-08-08","kind":"sale","acquired":false,"shares":626,"price":11.82,"value":7399.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":101362,"source":{"system":"sec-edgar","filing":"0001179110-19-009338","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019009338/edgar.xml","form_type":"4"}},{"id":3442216,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-08-09T16:20:01.000Z","date":"2019-08-07","kind":"exercise","acquired":true,"shares":1409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1061 shares acquired under the issuer's employee stock purchase plan at a price of $9.61 per share on July 31, 2019."}],"balance_after":101988,"source":{"system":"sec-edgar","filing":"0001179110-19-009338","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019009338/edgar.xml","form_type":"4"}},{"id":3527461,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-14T18:56:23.000Z","date":"2019-05-10","kind":"exercise","acquired":true,"shares":2998,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.26,"exercise_date":"2012-02-22","expiration_date":"2021-02-22","underlying":"Common Stock","underlying_shares":2998},"source":{"system":"sec-edgar","filing":"0001179110-19-006034","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019006034/edgar.xml","form_type":"4"}},{"id":3527460,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-05-14T18:56:23.000Z","date":"2019-05-10","kind":"exercise","acquired":true,"shares":2998,"price":13.26,"value":39753.48,"ownership":{"direct":true},"balance_after":99518,"source":{"system":"sec-edgar","filing":"0001179110-19-006034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019006034/edgar.xml","form_type":"4"}},{"id":3527459,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-05-14T18:56:23.000Z","date":"2019-05-10","kind":"sale","acquired":false,"shares":354,"price":14,"value":4956.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":96520,"source":{"system":"sec-edgar","filing":"0001179110-19-006034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019006034/edgar.xml","form_type":"4"}},{"id":3533393,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2019-05-09T16:25:08.000Z","date":"2019-05-07","kind":"exercise","acquired":false,"shares":1410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":9866,"derivative":{"underlying":"Common Stock","underlying_shares":1410},"source":{"system":"sec-edgar","filing":"0001179110-19-005768","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019005768/edgar.xml","form_type":"4"}},{"id":3533392,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-05-09T16:25:08.000Z","date":"2019-05-08","kind":"sale","acquired":false,"shares":419,"price":13.68,"value":5731.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":96874,"source":{"system":"sec-edgar","filing":"0001179110-19-005768","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019005768/edgar.xml","form_type":"4"}},{"id":3533391,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-05-09T16:25:08.000Z","date":"2019-05-07","kind":"exercise","acquired":true,"shares":1410,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":97293,"source":{"system":"sec-edgar","filing":"0001179110-19-005768","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019005768/edgar.xml","form_type":"4"}},{"id":3554954,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-04-16T17:04:24.000Z","date":"2019-04-13","kind":"disposition_to_issuer","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":95883,"source":{"system":"sec-edgar","filing":"0001179110-19-004993","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019004993/edgar.xml","form_type":"4"}},{"id":3638431,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-02-22T16:03:59.000Z","date":"2019-02-20","kind":"sale","acquired":false,"shares":351,"price":14.05,"value":4931.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":125883,"source":{"system":"sec-edgar","filing":"0001179110-19-002310","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019002310/edgar.xml","form_type":"4"}},{"id":3649313,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-02-19T16:53:28.000Z","date":"2019-02-14","kind":"sale","acquired":false,"shares":4450,"price":13.1,"value":58295.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":126234,"source":{"system":"sec-edgar","filing":"0001179110-19-002089","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019002089/edgar.xml","form_type":"4"}},{"id":3656194,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-14T16:27:50.000Z","date":"2019-02-12","kind":"exercise","acquired":false,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 12, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date."}],"balance_after":27500,"derivative":{"underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001179110-19-001907","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019001907/edgar.xml","form_type":"4"}},{"id":3656193,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-02-14T16:27:50.000Z","date":"2019-02-13","kind":"sale","acquired":false,"shares":8358,"price":12.7,"value":106146.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":130684,"source":{"system":"sec-edgar","filing":"0001179110-19-001907","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019001907/edgar.xml","form_type":"4"}},{"id":3656192,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-02-14T16:27:50.000Z","date":"2019-02-12","kind":"exercise","acquired":true,"shares":27500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":139042,"source":{"system":"sec-edgar","filing":"0001179110-19-001907","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019001907/edgar.xml","form_type":"4"}},{"id":3660008,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-13T16:43:46.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents options granted by the issuer pursuant to the issuer's 2013 Incentive Award Plan, as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest and become exercisable with respect to 33,750 shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years. All vesting is subject to Young Kwon's continued service to the Company through the applicable vesting date."}],"balance_after":135000,"derivative":{"exercise_price":12.76,"expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001179110-19-001834","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019001834/edgar.xml","form_type":"4"}},{"id":3660007,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-02-13T16:43:46.000Z","date":"2019-02-12","kind":"sale","acquired":false,"shares":414,"price":12.77,"value":5286.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":111542,"source":{"system":"sec-edgar","filing":"0001179110-19-001834","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019001834/edgar.xml","form_type":"4"}},{"id":3665635,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-11T16:24:41.000Z","date":"2019-02-07","kind":"exercise","acquired":false,"shares":1409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years."}],"balance_after":11276,"derivative":{"underlying":"Common Stock","underlying_shares":1409},"source":{"system":"sec-edgar","filing":"0001179110-19-001700","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019001700/edgar.xml","form_type":"4"}},{"id":3665634,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-02-11T16:24:41.000Z","date":"2019-02-08","kind":"sale","acquired":false,"shares":494,"price":11.52,"value":5690.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":111956,"source":{"system":"sec-edgar","filing":"0001179110-19-001700","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019001700/edgar.xml","form_type":"4"}},{"id":3665633,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-02-11T16:24:41.000Z","date":"2019-02-07","kind":"exercise","acquired":true,"shares":1409,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":112450,"source":{"system":"sec-edgar","filing":"0001179110-19-001700","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019001700/edgar.xml","form_type":"4"}},{"id":3754442,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-11-21T16:24:28.000Z","date":"2018-11-20","kind":"sale","acquired":false,"shares":535,"price":12.3,"value":6580.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":111041,"source":{"system":"sec-edgar","filing":"0001179110-18-013085","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911018013085/edgar.xml","form_type":"4"}},{"id":3764383,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":66864,"kind":"person","name":"KWON YOUNG","position":1,"cik":"0001733094","reported_name":"KWON YOUNG","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-11-14T16:31:31.000Z","date":"2018-11-12","kind":"sale","acquired":false,"shares":530,"price":13.15,"value":6969.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":111576,"source":{"system":"sec-edgar","filing":"0001179110-18-012844","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911018012844/edgar.xml","form_type":"4"}}],"next_cursor":"2018-11-14T16:31:31.000000Z,3764383"}